Save information for later
Sign Up

Learn About Charcot-Marie-Tooth Disease

What is the definition of Charcot-Marie-Tooth Disease?

Charcot-Marie-Tooth disease encompasses a group of disorders called hereditary sensory and motor neuropathies that damage the peripheral nerves. Peripheral nerves connect the brain and spinal cord to muscles and to sensory cells that detect sensations such as touch, pain, heat, and sound. Damage to the peripheral nerves that worsens over time can result in alteration or loss of sensation and wasting (atrophy) of muscles in the feet, legs, and hands.

What are the causes of Charcot-Marie-Tooth Disease?

Charcot-Marie-Tooth disease can be caused by mutations in many different genes. These genes provide instructions for making proteins that are involved in the function of peripheral nerves in the feet, legs, and hands. The gene mutations that cause Charcot-Marie-Tooth disease affect the function of the proteins in ways that are not fully understood; however, they likely impair axons, which transmit nerve impulses, or affect the specialized cells that produce myelin. In most cases, longer nerves that transmit impulses to the appendages of the body are more likely to be affected. As a result, peripheral nerve cells slowly lose the ability to stimulate the muscles in the feet, legs, and eventually the hands, and to transmit sensory signals from these appendages to the brain. Different mutations within a single gene may cause signs and symptoms of differing severities or lead to different types of Charcot-Marie-Tooth disease.

How prevalent is Charcot-Marie-Tooth Disease?

Charcot-Marie-Tooth disease is the most common inherited disorder that involves the peripheral nerves, affecting an estimated 150,000 people in the United States. It occurs in populations worldwide with a prevalence of about 1 in 3,300 individuals.

Is Charcot-Marie-Tooth Disease an inherited disorder?

The pattern of inheritance varies with the type of Charcot-Marie-Tooth disease. CMT1, most cases of CMT2, and most intermediate forms are inherited in an autosomal dominant pattern. This pattern of inheritance means that one copy of the altered gene in each cell is sufficient to cause the disorder. In most cases, an affected person has one affected parent. Each of the children of an affected parent has a 50 percent chance of inheriting the disorder.

Who are the top Charcot-Marie-Tooth Disease Local Doctors?
Family Medicine
Family Medicine

Baylor Scott & White Personal Edge - Dallas

9101 N Central Expy, Ste 440, 
Dallas, TX 
 (12.1 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Chad Coleman is a Family Medicine provider in Dallas, Texas. Dr. Coleman and is rated as an Experienced provider by MediFind in the treatment of Charcot-Marie-Tooth Disease. His top areas of expertise are Acute Cystitis, Chronic Recurrent Multifocal Osteomyelitis, Urinary Tract Infection (UTI), and Urinary Tract Infection in Children. Dr. Coleman is currently accepting new patients.

8330 Meadow Rd, Suite 204, 
Dallas, TX 
 (13.2 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Ziad Blaik is a Neurologist in Dallas, Texas. Dr. Blaik and is rated as an Experienced provider by MediFind in the treatment of Charcot-Marie-Tooth Disease. His top areas of expertise are Progressive Myoclonic Epilepsy, Lafora Disease, Unverricht-Lundborg Syndrome, and Neurofibromatosis Type 1 (NF1). Dr. Blaik is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Pain Medicine | Physiatry
Pain Medicine | Physiatry
613 S Hwy 78, Suite 200, 
Wylie, TX 
 (14.5 mi)
Languages Spoken:
English, Arabic, Spanish
Accepting New Patients
Offers Telehealth

Ahmed Mahmoud is a Pain Medicine specialist and a Physiatrist in Wylie, Texas. Dr. Mahmoud and is rated as an Experienced provider by MediFind in the treatment of Charcot-Marie-Tooth Disease. His top areas of expertise are Necrotizing Myopathy (NM), Chronic Subdural Hematoma, Stroke, and Subdural Hematoma. Dr. Mahmoud is currently accepting new patients.

What are the latest Charcot-Marie-Tooth Disease Clinical Trials?
A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of NMD670 Over 21 Days in Ambulatory Adult Patients With Type 1 and Type 2 Charcot-Marie-Tooth Disease

Summary: This Phase 2a study aims to evaluate the efficacy, safety and tolerability of NMD670 vs placebo administered twice a day (BID) for 21 days in ambulatory adult patients with Charcot-Marie-Tooth disease type 1 and type.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Universal Genomic Newborn Screening in the Wallonia-Brussels Federation: Baby Detect

Summary: Newborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions. With a simple blood test, rare genetic conditions can be easily detected, and the early start of transformative treatment will help avoid severe disabilities and increase the quality of life. Baby Detect Project is an innovative NBS program using a pane...

Who are the sources who wrote this article ?

Published Date: October 01, 2018
Published By: National Institutes of Health